ABMT — Advanced Biomedical Technologies Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
- $0.01m
- $6.36m
- $0.12m
Annual balance sheet for Advanced Biomedical Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2016 October 31st | 2017 October 31st | 2018 October 31st | 2019 October 31st | 2020 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.007 | 0.007 | 0.007 | 0.006 | 0.202 |
| Net Total Receivables | 0.02 | 0.017 | 0.033 | 0.05 | 0.029 |
| Total Inventory | |||||
| Total Current Assets | 0.027 | 0.025 | 0.04 | 0.119 | 0.331 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.072 | 0.061 | 0.103 | 0.099 | 0.138 |
| Other Long Term Assets | |||||
| Total Assets | 0.101 | 0.085 | 0.142 | 0.218 | 0.469 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.46 | 5.08 | 5.76 | 6.7 | 7.86 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.46 | 5.08 | 5.76 | 6.7 | 7.87 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -4.36 | -5 | -5.62 | -6.48 | -7.4 |
| Total Liabilities & Shareholders' Equity | 0.101 | 0.085 | 0.142 | 0.218 | 0.469 |
| Total Common Shares Outstanding |